Hoechst Marion to launch latest anti-TB drug in India
-
16/12/1997
-
Financial Express (New Delhi)
Refapentine, the first new anti-TB drug on the global healtcare horizon after 30 years, was recently approved by the US Food and Drug Administration (FDA) for pulmonary tuberculosis.